Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Sabouret

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Expert Opinion on Pharmacotherapy|December 25, 2025
Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysisAhmed Ibrahim, Ali Saad Al-Shammari, Shrouk Ramadan, et al.
Reviews in Cardiovascular Medicine|November 10, 2025
Vitamin D and Cardiovascular Disease: The "Good", the "Bad", and the "Unknown"Domenico Mario Giamundo, Matteo Morello, Paola Pastena, et al.
European Journal of Internal Medicine|December 27, 2022
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?Pierre Sabouret, Luigi Spadafora, David Fischman, et al.
Minerva Cardiology and Angiology|July 5, 2023
Treatment adherence in patients without ST-elevation acute coronary syndromeLucía V Campos Cervera, Pierre Sabouret, Marco Bernardi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysisWaqas Ullah, Salman Zahid, Harigopal Sandhyavenu, et al.
Archives of Cardiovascular Diseases|July 15, 2020
Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of CardiologyNathan Mewton, Nicolas Girerd, Jean-Jacques Boffa, et al.
Journal of Clinical Medicine|March 28, 2026
Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented StrategiesPierre Sabouret, Domenico Mario Giamundo, Francesco Costa, et al.
Archives of Medical Science : AMS|July 14, 2022
Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paperPierre Sabouret, Gilles Lemesle, Anne Bellemain-Appaix, et al.
Journal of Clinical Medicine|August 14, 2025
High Sensitive Cardiac Troponin-I (Hs-cTnI) Levels in Asymptomatic Hemodialysis PatientsOfir Rabi, Linda Shavit, Ranel Loutati, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Validation of Takotsubo Syndrome Scoring SystemDana Deeb, Ranel Loutati, Louay Taha, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Expert Opinion on Pharmacotherapy|December 25, 2025
Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysisAhmed Ibrahim, Ali Saad Al-Shammari, Shrouk Ramadan, et al.
Reviews in Cardiovascular Medicine|November 10, 2025
Vitamin D and Cardiovascular Disease: The "Good", the "Bad", and the "Unknown"Domenico Mario Giamundo, Matteo Morello, Paola Pastena, et al.
European Journal of Internal Medicine|December 27, 2022
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?Pierre Sabouret, Luigi Spadafora, David Fischman, et al.
Minerva Cardiology and Angiology|July 5, 2023
Treatment adherence in patients without ST-elevation acute coronary syndromeLucía V Campos Cervera, Pierre Sabouret, Marco Bernardi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysisWaqas Ullah, Salman Zahid, Harigopal Sandhyavenu, et al.
Archives of Cardiovascular Diseases|July 15, 2020
Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of CardiologyNathan Mewton, Nicolas Girerd, Jean-Jacques Boffa, et al.
Journal of Clinical Medicine|March 28, 2026
Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented StrategiesPierre Sabouret, Domenico Mario Giamundo, Francesco Costa, et al.
Archives of Medical Science : AMS|July 14, 2022
Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paperPierre Sabouret, Gilles Lemesle, Anne Bellemain-Appaix, et al.
Journal of Clinical Medicine|August 14, 2025
High Sensitive Cardiac Troponin-I (Hs-cTnI) Levels in Asymptomatic Hemodialysis PatientsOfir Rabi, Linda Shavit, Ranel Loutati, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Validation of Takotsubo Syndrome Scoring SystemDana Deeb, Ranel Loutati, Louay Taha, et al.
Pageof 14